English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The vesicular monoamine transporter type 2 (VMAT2) is believed to be responsible for the uptake of monoamines into the vesicles of the synaptic terminals. Two VMAT2 radioligands [ 11 C]DTBZ and [ 18 F]FP-DTBZ have been used to assess the degree of nigrostriatal deficit in Parkinson's disease (PD) using positron emission tomography (PET). [ 18 F]FE-DTBZ-d4, the nondeuterated analogue of [ 18 F]FE-DTBZ showed similar imaging properties with better stability against defluorination. Therefore, [ 18 F]FE-DTBZ-d4 draws attention to be investigated as an imaging marker for VMAT2 in the brain. The aim of this study was to investigate the brain kinetics and quantification of [ 18 F]FE-DTBZ-d4 in nonhuman primates (NHPs), with comparison to [ 11 C]DTBZ and [ 18 F]FE-DTBZ. Radiolabeling was successfully achieved either by one-step 11 C-methylation or by a two-step fluorine-18 nucleophilic substitution reaction. The stability and radiochemical yield were analyzed with high-performance liquid chromatography (HPLC). Three female cynomolgus monkeys were included in the study and underwent a total of 12 positron emission tomography (PET) measurements. Each monkey was examined with each tracer. In addition, two pretreatment and one displacement PET measurements with tetrabenazine (2.0 mg/kg) were performed for [ 18 F]FE-DTBZ-d4. All PET measurements were conducted using a high-resolution research tomograph (HRRT) system. Radiometabolites were measured in monkey plasma using gradient radio-HPLC. [ 18 F]FE-DTBZ-d4 (SUV: 4.28 ± 1.01) displayed higher brain uptake compared to both [ 18 F]FE-DTBZ (SUV: 3.43 ± 0.54) and [ 11 C]DTBZ (SUV: 3.06 ± 0.32) and faster washout. Binding potential (BP ND ) values of [ 18 F]FE-DTBZ-d4 in different brain regions (putamen: 5.5 ± 1.4; caudate: 4.4 ± 1.1; midbrain: 1.4 ± 0.4) were higher than those of [ 11 C]DTBZ and [ 18 F]FE-DTBZ. [ 18 F]FE-DTBZ showed faster radiometabolism in plasma compared to [ 11 C]DTBZ and [ 18 F]FE-DTBZ-d4. [ 18 F]FE-DTBZ-d4 is a suitable radioligand for quantification of VMAT2 in the nonhuman primate brain, with better imaging properties than [ 11 C]DTBZ and [ 18 F]FE-DTBZ. A preliminary comparison suggests that [ 18 F]FE-DTBZ-d4 has increased stability against defluorination compared to the nondeuterated analogue.

acs chemical neuroscience

PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ